Effect of exercise snacks on health in overweight/obese adults

The effect of 6-week high intensity interval training using an exercise snack training on metabolic, hepatic and Inflammatory markers in overweight/obese adults

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20241008063290N2

Enrollment

Registered

2026-05-05

Start date

2026-05-22

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight or obese adults.

Interventions

Intervention 1: Control group: Subjects in the control group will remain inactive throughout the study and will be advised to adhere to their normal daily routines. Intervention 2: Intervention group:

The intervention will be conducted at home over a period of six weeks, comprising three non-consecutive sessions per week. Each session will include two bouts separated by an interval of 1 to 4 hours.

This intervention will be conducted at home over a period of six weeks, comprising three non-consecutive sessions per week. Each session will include six bouts separated by intervals of 1 to 4 hours.

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Being adults Being in age range of 20–60 years Having overweight or obesity With a body mass index of 25–35 kg/m² Having general health

Exclusion criteria

Exclusion criteria: Having acute cardiovascular disease Following specific dietary regimens With weight instability (±5 kg) in the past 3 months Having any serious medical condition that precludes long-term participation in physical activity

Design outcomes

Primary

Measure	Time frame
Fasting blood glucose. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Using commercial kits via ELISA or enzymatic methods.;Fasting insulin. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Using commercial kits via ELISA or enzymatic methods.;Glycated hemoglobin (HbA1c). Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Using commercial kits via ELISA or enzymatic methods.;Insulin resistance. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: using the formula.;Alanine aminotransferase. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Using commercial kits via ELISA or enzymatic methods.;Aspartate aminotransferase. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Using commercial kits via ELISA or enzymatic methods.;Alkaline phosphatase. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Using commercial kits via ELISA or enzymatic methods.;Interleukin-6. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Using commercial kits via ELISA or enzymatic methods.;C-reactive protein. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Using commercial kits via ELISA or enzymatic methods.;Asprosin. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Using commercial kits via ELISA or enzymatic methods.;Subfatin. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Using commercial kits via ELISA or enzymatic methods.;Body weight. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Digital scale.;Height. Timepoint: At baseline. Method of measurement: Wall-mounted stadiometer.;Body mas	—

Measure

Time frame

Fasting blood glucose. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Using commercial kits via ELISA or enzymatic methods.;Fasting insulin. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Using commercial kits via ELISA or enzymatic methods.;Glycated hemoglobin (HbA1c). Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Using commercial kits via ELISA or enzymatic methods.;Insulin resistance. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: using the formula.;Alanine aminotransferase. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Using commercial kits via ELISA or enzymatic methods.;Aspartate aminotransferase. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Using commercial kits via ELISA or enzymatic methods.;Alkaline phosphatase. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Using commercial kits via ELISA or enzymatic methods.;Interleukin-6. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Using commercial kits via ELISA or enzymatic methods.;C-reactive protein. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Using commercial kits via ELISA or enzymatic methods.;Asprosin. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Using commercial kits via ELISA or enzymatic methods.;Subfatin. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Using commercial kits via ELISA or enzymatic methods.;Body weight. Timepoint: At baseline and 48 hours after the last exercise session. Method of measurement: Digital scale.;Height. Timepoint: At baseline. Method of measurement: Wall-mounted stadiometer.;Body mas

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamid Rajabi

Kharazmi University

hrajabi@khu.ac.ir0098 21 88329220-3

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026